Reading view
A consumer watchdog issued a warning about Google’s AI agent shopping protocol — Google says she’s wrong
ConSensus: Multi-Agent Collaboration for Multimodal Sensing
SafePro: Evaluating the Safety of Professional-Level AI Agents
Puzzle it Out: Local-to-Global World Model for Offline Multi-Agent Reinforcement Learning
Why Slop Matters
PulseMind: A Multi-Modal Medical Model for Real-World Clinical Diagnosis
FairMedQA: Benchmarking Bias in Large Language Models for Medical Question Answering
Generative Digital Twins: Vision-Language Simulation Models for Executable Industrial Systems
Interpretable inflammation landscape of circulating immune cells
Nature Medicine, Published online: 12 January 2026; doi:10.1038/s41591-025-04126-3
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.Safety Not Found (404): Hidden Risks of LLM-Based Robotics Decision Making
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-z
Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.Surface-based Molecular Design with Multi-modal Flow Matching
Belief in Authority: Impact of Authority in Multi-Agent Evaluation Framework
Atlas 2 -- Foundation models for clinical deployment
PsychEval: A Multi-Session and Multi-Therapy Benchmark for High-Realism AI Psychological Counselor
A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study
An autonomous agentic workflow for clinical detection of cognitive concerns using large language models
npj Digital Medicine, Published online: 07 January 2026; doi:10.1038/s41746-025-02324-4
An autonomous agentic workflow for clinical detection of cognitive concerns using large language modelsAdaptive therapy for perioperative non-small cell lung cancer: strategies guided by dynamic minimal residual disease adjustment
Transl Oncol. 2026 Jan 6;64:102660. doi: 10.1016/j.tranon.2025.102660. Online ahead of print.
ABSTRACT
Lung cancer remains the leading cause of cancer incidence and mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for about 85% of cases. The low rate of early diagnosis and the high rate of occult metastases limit the survival benefits of conventional treatments. The current TNM staging system fails to fully reflect tumor heterogeneity or the dynamic molecular evolution of the disease, thus affecting the prediction of recurrence and the prognostic stratification. Some recent advances in minimal residual disease (MRD) detection, such as ultra-sensitive liquid biopsy technologies, have largely overcome the limitations of traditional imaging and offered a transformative approach for continuous, precision-based management of lung cancer. This review systematically summarized the technological evolution of MRD detection and highlighted its clinical significance in guiding adaptive therapy for NSCLC, including treatment escalation, de-escalation, and the emerging concept of precision-guided drug holidays. Moreover, the authors comprehensively discussed the "Four-Dimensional TNMB Staging System," which incorporates continuous molecular monitoring to address the static limitations of conventional staging and enhance the accuracy of prognostic stratification. Although ongoing challenges, such as the lack of standardized interpretation criteria and limited detection sensitivity, the combinations with the third-generation liquid biopsy platforms, multi-omics analyses, and multi-center prospective validation studies are expected to advance the clinical implementation of MRD-guided strategies. The paradigm change will enable the transition of NSCLC management from conventional standardized models to a precision-guided, closed-loop system of "monitoring-intervention-remonitoring," establishing a solid theoretical and practical foundation for comprehensive, molecularly driven management strategies.
PMID:41496417 | DOI:10.1016/j.tranon.2025.102660